Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-20-002521

CHIEF EXECUTIVE OFFICER gave up 625 shares (to pay taxes)

  • CHIEF EXECUTIVE OFFICER acquired 1,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-10-30 Option exercise +1,875 9,382 D: show line 1 in the form
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-10-30 Shares withheld for taxes −625 $2.53 $1,581 8,757 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Williams Gregory C. CHIEF EXECUTIVE OFFICER 2020-10-30 Option exercise · Restricted Stock Units −1,875 16,875 D: show line 3 in the form
Loading xslF345X03/form4-11022020_041107.xml…